BioNTech SE (BNTX) stock
BNTXNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$84.86−0.40 (-0.47%)
Close on Nov 17, 2026Market cap $21.32BP/E –Yield –
BioNTech pe ratio
The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.
BioNTech's pe ratio was 28.3× on Feb 28, 2025, against 2.2× a year earlier. Over the last 3 years it ranged from 2.2× to 31.1×, with a median of 3.6×.
PE Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2025 | Feb 28, 2025 | 28.3× | −0.4 |
| 2024 | Dec 31, 2024 | 28.7× | +26.2 |
| 2023 | Dec 29, 2023 | 2.5× | −1.0 |
| 2022 | Dec 30, 2022 | 3.5× | – |
See a number that looks wrong?